Bank of New York Mellon’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.1K Sell
19,124
-290,995
-94% -$275K ﹤0.01% 4096
2025
Q1
$143K Sell
310,119
-4,800
-2% -$2.21K ﹤0.01% 3936
2024
Q4
$233K Buy
314,919
+139
+0% +$103 ﹤0.01% 3875
2024
Q3
$494K Sell
314,780
-87,128
-22% -$137K ﹤0.01% 3517
2024
Q2
$675K Buy
401,908
+109,902
+38% +$185K ﹤0.01% 3399
2024
Q1
$701K Sell
292,006
-49,071
-14% -$118K ﹤0.01% 3326
2023
Q4
$522K Buy
341,077
+9,754
+3% +$14.9K ﹤0.01% 3523
2023
Q3
$361K Sell
331,323
-6,352
-2% -$6.92K ﹤0.01% 3718
2023
Q2
$773K Buy
337,675
+20,173
+6% +$46.2K ﹤0.01% 3351
2023
Q1
$772K Sell
317,502
-8,516
-3% -$20.7K ﹤0.01% 3251
2022
Q4
$623K Buy
326,018
+34,358
+12% +$65.6K ﹤0.01% 3439
2022
Q3
$699K Buy
291,660
+34,564
+13% +$82.8K ﹤0.01% 3384
2022
Q2
$478K Sell
257,096
-27,514
-10% -$51.2K ﹤0.01% 3625
2022
Q1
$595K Buy
284,610
+362
+0.1% +$757 ﹤0.01% 3609
2021
Q4
$1.12M Buy
284,248
+23,258
+9% +$91.6K ﹤0.01% 3319
2021
Q3
$1.26M Buy
260,990
+19,655
+8% +$94.5K ﹤0.01% 3269
2021
Q2
$1.11M Buy
241,335
+39,919
+20% +$183K ﹤0.01% 3342
2021
Q1
$1.18M Buy
201,416
+13,821
+7% +$81.1K ﹤0.01% 3241
2020
Q4
$641K Sell
187,595
-321,671
-63% -$1.1M ﹤0.01% 3486
2020
Q3
$733K Sell
509,266
-62,085
-11% -$89.4K ﹤0.01% 3298
2020
Q2
$1.14M Sell
571,351
-174,914
-23% -$349K ﹤0.01% 3031
2020
Q1
$1.46M Sell
746,265
-48,611
-6% -$94.8K ﹤0.01% 2720
2019
Q4
$3.3M Buy
794,876
+609,611
+329% +$2.53M ﹤0.01% 2550
2019
Q3
$557K Sell
185,265
-5,624
-3% -$16.9K ﹤0.01% 3469
2019
Q2
$1.2M Sell
190,889
-5,312
-3% -$33.4K ﹤0.01% 3093
2019
Q1
$1.09M Buy
196,201
+8,798
+5% +$48.9K ﹤0.01% 3113
2018
Q4
$1.24M Sell
187,403
-1,336
-0.7% -$8.87K ﹤0.01% 2987
2018
Q3
$2.01M Sell
188,739
-7,471
-4% -$79.7K ﹤0.01% 2828
2018
Q2
$2.35M Sell
196,210
-7,617
-4% -$91.4K ﹤0.01% 2764
2018
Q1
$1.75M Buy
203,827
+3,579
+2% +$30.7K ﹤0.01% 2880
2017
Q4
$1.98M Sell
200,248
-2,869
-1% -$28.4K ﹤0.01% 2838
2017
Q3
$2.5M Sell
203,117
-52,755
-21% -$649K ﹤0.01% 2712
2017
Q2
$4.21M Sell
255,872
-24,381
-9% -$401K ﹤0.01% 2409
2017
Q1
$4.02M Buy
280,253
+19,176
+7% +$275K ﹤0.01% 2432
2016
Q4
$3.61M Buy
261,077
+20,155
+8% +$279K ﹤0.01% 2505
2016
Q3
$4.35M Buy
240,922
+46,756
+24% +$845K ﹤0.01% 2300
2016
Q2
$2.79M Sell
194,166
-2,098
-1% -$30.1K ﹤0.01% 2521
2016
Q1
$2.35M Sell
196,264
-4,686
-2% -$56K ﹤0.01% 2570
2015
Q4
$2.68M Sell
200,950
-1,039
-0.5% -$13.8K ﹤0.01% 2539
2015
Q3
$2.17M Sell
201,989
-27,858
-12% -$299K ﹤0.01% 2679
2015
Q2
$1.85M Buy
229,847
+17,601
+8% +$142K ﹤0.01% 2973
2015
Q1
$1.4M Buy
212,246
+24,142
+13% +$160K ﹤0.01% 3095
2014
Q4
$1.2M Sell
188,104
-2,617
-1% -$16.7K ﹤0.01% 3190
2014
Q3
$1.88M Buy
190,721
+15,679
+9% +$155K ﹤0.01% 2926
2014
Q2
$1.97M Sell
175,042
-8,571
-5% -$96.6K ﹤0.01% 2906
2014
Q1
$2.22M Sell
183,613
-16,970
-8% -$206K ﹤0.01% 2813
2013
Q4
$2.53M Sell
200,583
-1,002
-0.5% -$12.6K ﹤0.01% 2739
2013
Q3
$3.36M Sell
201,585
-21,221
-10% -$354K ﹤0.01% 2491
2013
Q2
$3.39M Buy
+222,806
New +$3.39M ﹤0.01% 2426